Results 61 to 70 of about 134 (91)

An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review. [PDF]

Einstein (Sao Paulo), 2015
Bougea A, Anagnostou E, Spandideas N, Triantafyllou N, Kararizou E.   +4 more
europepmc   +1 more source

[Virus and systemic vasculitis]. [PDF]

Rev Clin Esp, 2006
Cervantes Bonet B, Callejas Rubio JL, Ortego Centeno N.   +2 more
europepmc   +1 more source

Enfermedades inflamatorias nasales y de senos parasales. [PDF]

Medicine (Baltimore), 2011
Guerrero Ríos JA, Sánchez Camón I, Chachi Parra E, Rivera Rodríguez T.   +3 more
europepmc   +1 more source

Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey. [PDF]

Rheumatology (Oxford)
Conticini E, Emmi G, Grazzini S, André M, Cohen Tervaert JW, Durante E, Torracca F, Mohammad AJ, Moosig F, Neumann T, Solans Laque R, Terrier B, Vaglio A, Cameli P, European EGPA Study Group (EESG).   +14 more
europepmc   +1 more source

[Therapeutic innovations in the treatment of asthma]. [PDF]

Aten Primaria, 2001
Llop R, Vallano A, Rodríguez D, Diogene E.   +3 more
europepmc   +1 more source

Rapidly progressive antineutrophil cytoplasm antibodies associated with pulmonary-renal syndrome in a 10-year-old girl. [PDF]

Sao Paulo Med J, 2001
Blanco Filho F, Ernesto LC, Rosa MA, Stuginski LA, Zlochevsky ER, Blanco F.   +5 more
europepmc   +1 more source

[Wells Syndrome: Clinical Presentation and Literature Review]. [PDF]

Rev Med Inst Mex Seguro Soc
Vega-Del Pilar YX, Chew-Bonilla E, Felix-Guerrero LL, Miranda-Contreras NI, Lemini-López A.   +4 more
europepmc   +1 more source

Congestive cardiomyopathy and endobronchial granulomas as manifestations of Churg-Strauss syndrome. [PDF]

Postgrad Med J, 1995
Alvarez-Sala R, Prados C, Armada E, Del Arco A, Villamor J.   +4 more
europepmc   +1 more source

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study. [PDF]

Rheumatology (Oxford)
Delvino P, Quartuccio L, Robson JC, Ferretti VV, Klersy C, Alberici F, Bagnasco D, Berti A, Caminati M, Camoni M, Cid MC, Conticini E, Costanzo G, de Moreuil C, Del Giacco S, Espigol-Frigole G, Franceschini F, Iorio L, Kernder A, Lo Gullo A, Losappio L, Manna E, Maule M, Milanesi A, Montecucco C, Negrini S, Padoan R, Regola F, Ricciardi L, Schroeder J, Terrier B, Toniati P, Torracca F, Treppo E, Urban ML, Vaglio A, Emmi G, Monti S, European EGPA Study Group.   +38 more
europepmc   +1 more source

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. [PDF]

Arthritis Res Ther, 2011
Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M, BIOGEAS Study Group.   +18 more
europepmc   +1 more source